Englewood Hospital Celebrates A 1000th Procedure Milestone

ENGLEWOOD, NJ — Englewood Hospital announced this Monday that their heart valve team performed their 1000th transcatheter aortic valve replacement (TAVR).

The procedure was done on a patient suffering from aortic stenosis, a debilitating type of heart disease.

According to the Englewood Hospital, it became one of the first hospitals in New Jersey to offer the procedure following its approval by the FDA in 2011 and it became one of the leading centers in New Jersey.

Originally the procedure was offered as an alternative to open-heart surgery for patients with a higher risk of complications due to their age.

“Through the support of our community we have created a program that provides local expertise with outcomes in the top 10% of the country," said Ramin Hastings, medical director of the structural heart and valve program. "Having cared for 1000 TAVR patients is a remarkable milestone for Englewood Health.”

Eliminating the need for open-heart surgery, the TAVR procedure allows an artificial valve to be implanted through a catheter that is inserted in the artery of the patient’s leg or chest.

The treatment offers patients a less-invasive option with a quicker recovery, generally allowing them to return home the next day.

"We are extremely proud of this huge accomplishment,” said Denise Goldstein, structural heart and valve program coordinator at Englewood Hospital.